Advertisement

Topics

Clovis soars on strong results for PARP inhibitor

05:29 EDT 19 Jun 2017 | BioPharmaDive

Results from the ARIEL-3 study could expand Rubraca's market opportunity and position the drug more competitively versus rivals.

Original Article: Clovis soars on strong results for PARP inhibitor

NEXT ARTICLE

More From BioPortfolio on "Clovis soars on strong results for PARP inhibitor"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...